Titleman Orthopedic Inc Philadelphia, PA - 19111

Titleman Orthopedic Inc is categorized under Orthopedic Doctors and Physicians in Philadelphia, PA and active since 1979.

Titleman Orthopedic Inc was established in 1979, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 4461990 by the NAICS.

If you are seeking more information, feel free to contact Alan Titleman, Owner at the company’s single location by writing to 336 Loney St, Philadelphia, Pennsylvania PA 19111 or by phoning (215) 722-0751. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Titleman Orthopedic Inc
Contact Person: Alan Titleman, Owner
Address: 336 Loney St, Philadelphia, Pennsylvania 19111
Phone Number: (215) 722-0751
Annual Revenue (USD): $100.000 to $499.999
Founded: 1979
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Orthopedic Doctors and Physicians
SIC Code: 8011
NAICS Code: 4461990
Share This Business:

Titleman Orthopedic Inc was started in 1979 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 4461990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Alan Titleman, Owner for inquiries that concern Titleman Orthopedic Inc by calling the company number (215) 722-0751, as your correspondence is most welcome. Additionally, the physical location of the single location of Titleman Orthopedic Inc can be found at the coordinates 40.07631,-75.08573 as well as the street address 336 Loney St in Philadelphia, Pennsylvania 19111.

For its online presence, you may visit Titleman Orthopedic Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.